Jump to content
RemedySpot.com

Novel F141L Pre-S2 Mutation in Hepatitis B Virus Increases the Risk of Hepatocellular Carcinoma in Patients with Chronic Genotype C Infections

Rate this topic


Recommended Posts

Posted

http://jvi.asm.org/cgi/content/abstract/85/1/123

Journal of Virology, January 2011, p. 123-132, Vol. 85, No. 1

0022-538X/11/$012.00+0 doi:10.1128/JVI.01524-10

Copyright © 2011, American Society for Microbiology. .

Novel F141L Pre-S2 Mutation in Hepatitis B Virus Increases the Risk of

Hepatocellular Carcinoma in Patients with Chronic Genotype C Infections

Ho-Suk Mun, Seoung-Ae Lee, Hong Kim, Eung-Soo Hwang, Yoon-Hoh Kook, and Bum-Joon

Kim*

Department of Microbiology and Immunology, Liver Research Institute, Cancer

Research Institute and SNUMRC, College of Medicine, Seoul National University,

Seoul, South Korea

Received 22 July 2010/ Accepted 13 October 2010

Several lines of evidence have suggested that some naturally occurring mutations

of hepatitis B virus (HBV) play a critical role in hepatocellular carcinoma

(HCC). Here, we describe a novel HCC-related pre-S2 mutation, F141L. To prove

the relationship between the F141L mutation and HCC, molecular epidemiology

studies using MboII PCR restriction analysis (PRA) were performed, and the

molecular mechanism was investigated through construction of a stable hepatocyte

cell line expressing the large surface HB protein (LHB) with the F141L mutation

(F141L-LHB). Application of MboII PRA to samples from 241 Korean patients with

chronic liver diseases of different clinical stages confirmed that F141L mutants

were significantly related to HCC, even in comparison to liver cirrhosis (HCC,

26.3% of patients, or 26/99; liver cirrhosis, 3.8% of patients, or 2/52; P =

0.001). By studying stable cell lines, we found that F141L-LHBs could induce

cell cycle progression by downregulating the p53 and p21 pathways and

upregulating CDK4 and cyclin A. Furthermore, we found that in a colony-forming

assay, the colony-forming rates in cell lines expressing F141L-LHBs were about

twice as high as those of the wild type. In conclusion, our results suggest that

F141L-LHBs may contribute importantly to the pathogenesis of HCC by inducing

cell proliferation and transformation. So, the F141L mutation examined in this

study could serve as a diagnostic marker for the prognosis of HCC.

--------------------------------------------------------------------------------

* Corresponding author. Mailing address: Department of Microbiology and

Immunology, Liver Research Institute and Cancer Research Institute, College of

Medicine, Seoul National University, 28 Yongon-dong, Chongno-gu, Seoul 110-799,

South Korea. Phone: (82) 2 740 8316. Fax: (82) 2 743 0881. E-mail:

kbumjoon@...

Published ahead of print on 20 October 2010.

Posted

http://jvi.asm.org/cgi/content/abstract/85/1/123

Journal of Virology, January 2011, p. 123-132, Vol. 85, No. 1

0022-538X/11/$012.00+0 doi:10.1128/JVI.01524-10

Copyright © 2011, American Society for Microbiology. .

Novel F141L Pre-S2 Mutation in Hepatitis B Virus Increases the Risk of

Hepatocellular Carcinoma in Patients with Chronic Genotype C Infections

Ho-Suk Mun, Seoung-Ae Lee, Hong Kim, Eung-Soo Hwang, Yoon-Hoh Kook, and Bum-Joon

Kim*

Department of Microbiology and Immunology, Liver Research Institute, Cancer

Research Institute and SNUMRC, College of Medicine, Seoul National University,

Seoul, South Korea

Received 22 July 2010/ Accepted 13 October 2010

Several lines of evidence have suggested that some naturally occurring mutations

of hepatitis B virus (HBV) play a critical role in hepatocellular carcinoma

(HCC). Here, we describe a novel HCC-related pre-S2 mutation, F141L. To prove

the relationship between the F141L mutation and HCC, molecular epidemiology

studies using MboII PCR restriction analysis (PRA) were performed, and the

molecular mechanism was investigated through construction of a stable hepatocyte

cell line expressing the large surface HB protein (LHB) with the F141L mutation

(F141L-LHB). Application of MboII PRA to samples from 241 Korean patients with

chronic liver diseases of different clinical stages confirmed that F141L mutants

were significantly related to HCC, even in comparison to liver cirrhosis (HCC,

26.3% of patients, or 26/99; liver cirrhosis, 3.8% of patients, or 2/52; P =

0.001). By studying stable cell lines, we found that F141L-LHBs could induce

cell cycle progression by downregulating the p53 and p21 pathways and

upregulating CDK4 and cyclin A. Furthermore, we found that in a colony-forming

assay, the colony-forming rates in cell lines expressing F141L-LHBs were about

twice as high as those of the wild type. In conclusion, our results suggest that

F141L-LHBs may contribute importantly to the pathogenesis of HCC by inducing

cell proliferation and transformation. So, the F141L mutation examined in this

study could serve as a diagnostic marker for the prognosis of HCC.

--------------------------------------------------------------------------------

* Corresponding author. Mailing address: Department of Microbiology and

Immunology, Liver Research Institute and Cancer Research Institute, College of

Medicine, Seoul National University, 28 Yongon-dong, Chongno-gu, Seoul 110-799,

South Korea. Phone: (82) 2 740 8316. Fax: (82) 2 743 0881. E-mail:

kbumjoon@...

Published ahead of print on 20 October 2010.

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...